SCWorx Corp. (AMMA) [Rocket]

Overview

SCWorx Corp. (AMMA)

Add to portfolio

1m \| 3m \| 6m \| 1y \| 2y \| 5y \| 10y

Recent News + Filings (All items)

Date Filed	Type	Description
10/10/2023	8-K	Submission of Matters to a Vote of Security Holders, Other Events  Interactive Data
08/25/2023	3	Matozzo Vincent Michael (Director) has filed a Form 3 on SCWorx Corp.
08/22/2023	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/18/2023	DEF 14A	Form DEF 14A - Other definitive proxy statements:
08/14/2023	10-Q	Quarterly Report for the period ended June 30, 2023
08/09/2023	PRE 14A	Form PRE 14A - Other preliminary proxy statements:
08/03/2023	8-K	Other Events, Financial Statements and Exhibits  Interactive Data

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15
Revenues	4.6	5.2	5.5	3.4	0.2	0.6	0.0
Revenue growth	-11.1%	-6.0%	62.1%	1450.4%	-62.7%
Cost of goods sold	2.8	3.5	4.4	2.9	0.0	0.4	0.0
Gross profit	1.9	1.7	1.2	0.5	0.2	0.2	0.0
Gross margin	39.9%	32.6%	21.0%	14.8%	100.0%	35.0%
Selling, general and administrative							0.0
General and administrative	5.7	7.7	13.1	0.7	3.4	5.1	0.0
EBITA	-3.8	-5.8	-11.5	-0.3	-3.1	-4.5	0.0
EBITA margin	-82.3%	-112.0%	-207.1%	-7.7%	-1402.2%	-765.5%
Amortization of intangibles		0.2	0.0		0.1	0.4
EBIT	-3.8	-6.0	-11.5	-0.3	-3.2	-4.9	0.0
EBIT margin	-82.3%	-116.0%	-207.7%	-7.7%	-1436.8%	-830.5%
Pre-tax income	-3.8	-7.4	-11.3	-0.4	-3.2	-4.9	0.4
Income taxes	0.0	0.0	0.0	0.0	0.0	-0.8	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	15.4%	0.0%
Earnings from continuing ops	-3.8	-7.4	-11.3	-0.4	5.6	-4.2	0.4
Earnings from discontinued ops	-3.8	-7.4			-8.8
Net income	-3.8	-7.4	-11.3	-0.4	-3.2	-4.2	0.4
Net margin	-82.3%	-142.0%	-203.9%	-11.1%	-1436.8%	-703.3%

Diluted EPS	($0.36)	($0.82)	($1.81)	($0.09)	$0.50	($0.75)	$0.07
Shares outstanding (diluted)	10.5	9.1	6.3	4.5	11.2	5.5	5.3

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.